FDA approves obesity drug for sleep apnea

Описание к видео FDA approves obesity drug for sleep apnea

The FDA has approved Tirzepatide as the first medication specifically for obstructive sleep apnea in individuals with obesity. This GLP-1 receptor agonist has been shown to reduce apnea severity by nearly 66%, providing a new treatment option for better sleep and improved health.

#SleepApnea #MedicalNews #Tirzepatide #GLP1 #FDA #weightloss #maha #science #scicomm #letthedataspeak

Комментарии

Информация по комментариям в разработке

Похожие видео